China
· Delayed Price · Currency is CNY Pharmaron Beijing Company Description
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.
It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Production Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others.
The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development.
It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services.
In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies.
Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
| Country | China |
| Founded | 2004 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 21,370 |
| CEO | Boliang Lou |
Contact Details
Address: Building 1 Beijing, 100176 China | |
| Website | pharmaron.com |
Stock Details
| Ticker Symbol | 300759 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003JW4 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Dr. Boliang Lou Ph.D. | Chairman and Chief Executive Officer |
| Xiaoqiang Lou EMBA | Co-Founder, President, Chief Operating Officer and Executive Director |
| Shing Chung Li C.F.A., CPA | Chief Financial Officer and Secretary of the Board |
| Dr. Hua Yang Ph.D. | Chief Scientific Officer and Deputy Manager |
| Bei Zheng M.A, M.A. | Executive Vice President and Executive Director |
| Dr. Connie Sun Ph.D. | Senior Vice President and Global Head of Business Development of Small Molecules |
| Celina Zhong M.B.A., MBA | Senior Vice President of Human Resources |
| Katherine Lee M.B.A., MBA | Chief Business Officer |
| Stephen Lewinton | Senior Vice President of UK Operations |
| Dr. Jingqi Huang | Senior Vice President of In Vivo Pharmacology |